Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Biochemical and Biophysical Research Communications|September 19, 2006
alpha-Synuclein protects SH-SY5Y cells from dopamine toxicityMonica Colapinto, Silvia Mila, Sabrina Giraudo, et al.
Journal of Hepatology|January 15, 2018
Effects of the gut-liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liverLorenzo A Orci, Stéphanie Lacotte, Vaihere Delaune, et al.
Neuroscience|November 21, 2021
Brain Derived Neurotrophic Factor Deficiency is Associated with Cognitive Impairment and Elevated Phospholipase A2 Activity in Plasma of MiceMichaela Schmidt, Andrea Carlo Rossetti, Christiane Brandwein, et al.
Nature Medicine|March 30, 2010
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizuresMattia Maroso, Silvia Balosso, Teresa Ravizza, et al.
Brain, Behavior, and Immunity|October 19, 2016
Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's diseaseClaudia Balducci, Angelisa Frasca, Margherita Zotti, et al.
Molecular Medicine (Cambridge, Mass.)|May 8, 2012
Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degenerationMassimiliano De Paola, Alessandro Mariani, Paolo Bigini, et al.
Neurobiology of Disease|December 13, 2016
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsyValentina Iori, Anand M Iyer, Teresa Ravizza, et al.
Cells|November 11, 2022
Hyaluronan Regulates Neuronal and Immune Function in the Rat Small Intestine and Colonic Microbiota after Ischemic/Reperfusion InjuryAnnalisa Bosi, Davide Banfi, Michela Bistoletti, et al.
Nature Communications|October 13, 2025
Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoidsLea Zillich, Matteo Gasparotto, Andrea Carlo Rossetti, et al.
Radiation Oncology (London, England)|August 30, 2012
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatmentsMarta Scorsetti, Filippo Alongi, Antonella Fogliata, et al.
Pageof 4